Aetna (AET) Price Target Increased to $207.00 by Analysts at Credit Suisse Group

Share on StockTwits

Aetna (NYSE:AET) had its target price lifted by Credit Suisse Group from $202.00 to $207.00 in a report issued on Monday morning, The Fly reports. They currently have a neutral rating on the stock.

Several other brokerages have also recently commented on AET. Zacks Investment Research raised shares of Aetna from a hold rating to a buy rating and set a $228.00 price target on the stock in a research report on Thursday, October 4th. Cantor Fitzgerald lowered shares of Aetna from an overweight rating to a neutral rating and set a $202.00 price objective on the stock. in a research note on Wednesday, August 22nd. Finally, ValuEngine upgraded shares of Aetna from a hold rating to a buy rating in a research note on Tuesday, June 26th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus price target of $204.77.

Shares of NYSE:AET opened at $199.49 on Monday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. Aetna has a one year low of $159.23 and a one year high of $206.66. The stock has a market cap of $65.54 billion, a price-to-earnings ratio of 19.40, a price-to-earnings-growth ratio of 1.72 and a beta of 0.69.

Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 EPS for the quarter, topping the consensus estimate of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The firm had revenue of $15.56 billion for the quarter, compared to analysts’ expectations of $15.59 billion. During the same period in the previous year, the firm posted $3.42 EPS. The company’s revenue for the quarter was up .2% on a year-over-year basis. As a group, equities analysts forecast that Aetna will post 11.3 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 1.00%. Aetna’s dividend payout ratio is presently 20.28%.

Several institutional investors have recently added to or reduced their stakes in the company. Wolverine Asset Management LLC grew its stake in Aetna by 31.7% in the 2nd quarter. Wolverine Asset Management LLC now owns 47,351 shares of the company’s stock valued at $8,688,000 after buying an additional 11,408 shares during the last quarter. Pensionfund Sabic acquired a new position in Aetna in the 2nd quarter valued at about $2,569,000. Abrams Capital Management L.P. grew its stake in Aetna by 14.1% in the 2nd quarter. Abrams Capital Management L.P. now owns 1,575,000 shares of the company’s stock valued at $289,013,000 after buying an additional 195,000 shares during the last quarter. Havens Advisors LLC grew its stake in Aetna by 32.1% in the 3rd quarter. Havens Advisors LLC now owns 50,200 shares of the company’s stock valued at $10,183,000 after buying an additional 12,200 shares during the last quarter. Finally, Gabelli Funds LLC grew its stake in Aetna by 39.2% in the 2nd quarter. Gabelli Funds LLC now owns 226,139 shares of the company’s stock valued at $41,497,000 after buying an additional 63,639 shares during the last quarter. Institutional investors own 83.49% of the company’s stock.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

See Also: Intrinsic Value and Stock Selection

The Fly

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply